D2B3
New Haven
About D2B3
D2B3 is a pre-clinical biotechnology startup dedicated to creating innovative drug delivery technologies for the brain and central nervous system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $500.0K
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2025)
- Website: d2b3.bio
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/d2b3-62081 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.